Search results for "Particle size"

showing 10 items of 631 documents

A discoidal lipoprotein from the coelomic fluid of the polychaete Nereis virens.

2005

A discoidal lipoprotein was isolated from the coelomic fluid of the polychaete, Nereis virens, by density gradient centrifugation. The lipoprotein was present in both sexes and moved as a uniform band in an agarose gel. The average diameter of the lipoprotein particles determined by electron microscopy was 42 nm with a thickness of 10 nm. SDS electrophoresis showed two apoprotein subunits with molecular masses of 247 and 85 kDa, respectively. In lectin blots, both apoproteins were reactive with Concanavalin A indicating the presence of N-glycans. The small subunit was also reactive with peanut lectin, indicating additional O-glycosylation. The total lipid content was 48% and consisted mainl…

MaleEmbryo NonmammalianGlycosylationPhysiologyLipoproteinsBiologyIn Vitro TechniquesBiochemistrychemistry.chemical_compoundPolysaccharidesAnimalsParticle SizeMolecular BiologyDifferential centrifugationMolecular massLectinPolychaetaLipidsThin-layer chromatographyBody FluidsMolecular WeightElectrophoresisProtein SubunitschemistryBiochemistryConcanavalin Abiology.proteinAgaroselipids (amino acids peptides and proteins)FemaleLipoproteinComparative biochemistry and physiology. Part B, Biochemistrymolecular biology
researchProduct

In vivo biodistribution of amino-functionalized ceria nanoparticles in rats using positron emission tomography.

2012

A variety of nanoparticles have been proposed for several biomedical applications. To gauge the therapeutic potential of these nanoparticles, in vivo biodistribution is essential and mandatory. In the present study, ceria nanoparticles (5 nm average particle size) were labeled with F-18 to study their in vivo biodistribution in rats by positron emission tomography (PET). The F-18 isotope was anchored by reaction of N-succinimidyl 4-[F-18]fluorobenzoate (F-18-SFB) with a modified nanoparticle surface obtained by silylation with 3-aminopropylsilyl. Radiolabeled ceria nanoparticles accumulated mainly in lungs, spleen, and liver. Metabolic products of the radiolabeled nanoparticulate material w…

MaleFluorine RadioisotopesSilylationPharmaceutical ScienceNanoparticleNanotechnologyceria nanoparticlesBenzoatesAmino functionalizedRats Sprague-DawleyQUIMICA ORGANICADrug DiscoverymedicineImage Processing Computer-AssistedAnimalsTissue DistributionLungmedicine.diagnostic_testChemistryRadiochemistryrodentCeriumin vivo evaluationRatsPETLiverPositron emission tomographyIn vivo biodistributionPositron-Emission TomographyMolecular MedicineNanoparticlesParticle sizeRadiopharmaceuticalspharmacokineticsSpleenMolecular pharmaceutics
researchProduct

Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147.

2010

We present the preparation and isolation of different chemically modified BSA species with varying numbers of primary amino groups at the surface. Highly cationic albumin proteins with increased numbers of amino groups were achieved and complex formation with plasmid DNA was carefully investigated. We compare the transfection results, polyelectrolyte complexes morphologies with their impact on complex stabilities, cytotoxicities and DNA accessibility. This knowledge-driven approach led to the identification of the efficient non-viral DNA delivery agent cBSA-147, which showed high transfection efficacies and stability.

MaleGreen Fluorescent ProteinsStatic ElectricitySus scrofaBiophysicsSerum albuminBioengineeringEndosomesBiologyTransfectionBiomaterialschemistry.chemical_compoundElectrolytesPlasmidEthidiumStatic electricityAnimalsHumansParticle SizeCell DeathAlbuminIsothermal titration calorimetrySerum Albumin BovineTransfectionDNAMiddle AgedPolyelectrolyteClathrinMolecular WeightchemistryBiochemistryMechanics of MaterialsSpectrometry Mass Matrix-Assisted Laser Desorption-IonizationCeramics and CompositesBiophysicsbiology.proteinThermodynamicsDNAPlasmidsBiomaterials
researchProduct

Uptake and cytotoxicity of citrate-coated gold nanospheres : comparative studies on human endothelial and epithelial cells

2012

Abstract Background The use of gold nanoparticles (AuNPs) for diagnostic applications and for drug and gene-delivery is currently under intensive investigation. For such applications, biocompatibility and the absence of cytotoxicity of AuNPs is essential. Although generally considered as highly biocompatible, previous in vitro studies have shown that cytotoxicity of AuNPs in certain human epithelial cells was observed. In particular, the degree of purification of AuNPs (presence of sodium citrate residues on the particles) was shown to affect the proliferation and induce cytotoxicity in these cells. To expand these studies, we have examined if the effects are related to nanoparticle size (1…

MaleHealth Toxicology and Mutagenesis610 MedizinMetal Nanoparticles02 engineering and technologyToxicology01 natural scienceschemistry.chemical_compoundCoated Materials Biocompatible610 Medical sciencesQDCitratesCytotoxicityGeneral Medicine021001 nanoscience & nanotechnologyEndothelial stem cellmedicine.anatomical_structureColloidal goldBlood-Brain Barrier0210 nano-technologyNanospheresMaterials scienceEndotheliumCell SurvivalForeskinlcsh:Industrial hygiene. Industrial welfare010402 general chemistrySodium CitrateCell LineMicroscopy Electron Transmissionlcsh:RA1190-1270Sodium citratemedicineHumansViability assayParticle Sizelcsh:Toxicology. PoisonsCell ProliferationResearchCytoplasmic VesiclesEpithelial CellsQPIn vitro0104 chemical scienceschemistryCell culture[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieImmunologyBiophysics[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieEndothelium VascularGoldlcsh:HD7260-7780.8
researchProduct

Polymeric Nanocarriers for Magnetic Targeted Drug Delivery: Preparation, Characterization, and in Vitro and in Vivo Evaluation

2013

In this paper the preparation of magnetic nano- carriers (MNCs), containing superparamagnetic domains, is reported, useful as potential magnetically targeted drug delivery systems. The preparation of MNCs was performed by using the PHEA-IB-p(BMA) graft copolymer as coating material through the homogenization−solvent evaporation method. Magnetic and nonmagnetic nanocarriers containing flutamide (FLU-MNCs) were prepared. The prepared nanocarriers have been exhaustively characterized by dynamic light scattering (DLS), transmission electron microscopy (TEM), and magnetic measurements. Biological evaluation was performed by in vitro cytotoxicity and cell uptake tests and in vivo biodistribution …

MaleMaterials sciencePharmaceutical ScienceAntineoplastic AgentsNanotechnologyMagneticsDrug Delivery SystemsDynamic light scatteringIn vivoCell Line TumorDrug DiscoveryLNCaPAnimalsHumansDistribution (pharmacology)Tissue DistributionParticle SizeRats WistarMagnetite NanoparticlesDrug Carriersequipment and suppliesmagnetic nanocarrier magnetic targeting flutamide superparamagnetic nanoparticlesFlutamideIn vitroRatsTargeted drug deliverySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBiophysicsMolecular MedicineNanocarriersPeptideshuman activitiesSuperparamagnetismMolecular Pharmaceutics
researchProduct

Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects a…

2013

[Objective]: The PREDIMED trial showed that Mediterranean diets supplemented with either extra-virgin olive oil or nuts reduced incident cardiovascular events compared to a control diet. Consumption of both supplemental foods has been associated with reduced LDL-cholesterol, but it is unknown whether they can shift lipoprotein subfractions to a less atherogenic pattern. We investigated changes in adiposity and lipoprotein subfractions after consumption of the PREDIMED diets.

MalePREDIMEDmedicine.medical_specialtyMagnetic Resonance SpectroscopyTime FactorsWaistMediterranean dietLipoproteinsDiet MediterraneanHDL sizeDecreased LDLLDL sizeCohort StudiesRisk FactorsInternal medicinemedicineHumansPlant OilsNutsIncreased ldlParticle SizeSmall-dense LDLTriglyceridesAgedAged 80 and overVLDL sizebusiness.industryfood and beveragesCholesterol LDLMiddle AgedAtherosclerosisCircumferencePredimedLipoproteins LDLEndocrinologyCardiovascular DiseasesFemalelipids (amino acids peptides and proteins)Waist CircumferenceCardiology and Cardiovascular MedicinebusinessOlive oilLipoproteinOlive oil
researchProduct

Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir.

2001

Acyclovir-loaded polyethyl-2-cyanoacrylate (PECA) nanospheres were prepared by an emulsion polymerization process in the micellar phase and characterized. The influence of the presence of nonionic surfactant as well as other substances [i.e., 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CyD) and poly(ethylene glycol) (PEG)], on formulation parameters and loading capacity was investigated. In particular, the presence of PEG resulted in an increase of mean size and size distribution. To obtain PEG-coated PECA nanospheres with a mean size of200 nm, Pluronic F68 at concentrations1.5% (w/v) should be used during preparation. The presence of PEG also resulted in a change in zeta potential, from -25…

MalePharmaceutical ScienceEmulsion polymerizationAcyclovirBiological AvailabilityEyeAntiviral AgentsDosage formPolyethylene Glycolschemistry.chemical_compoundPEG ratioZeta potentialMucoadhesionOrganic chemistryAnimalsCyanoacrylatesParticle SizeDrug Carrierstechnology industry and agricultureMicrospheresBioavailabilitychemistryRabbitsDrug carrierEthylene glycolNuclear chemistryJournal of pharmaceutical sciences
researchProduct

Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients

2014

Abstract HDL-increasing drugs such as fenofibrate and niacin have failed to decrease the cardiovascular risk in patients with type 2 diabetes. Drug-mediated quantitative and qualitative HDL modifications could be involved in these negative results. To evaluate the quantitative and qualitative effects of niacin and fenofibrate on HDL in patients with type 2 diabetes, a prospective, randomised controlled intervention trial was conducted. Thirty type 2 diabetic patients with low HDL were randomised to receive either fenofibrate (FFB) or niacin + laropiprant (ERN/LPR) as an add-on to simvastatin treatment for 12 weeks according to a crossover design. At the basal point and after each interventi…

MaleSimvastatinIndolesTime FactorsType 2 diabetesHigh-Density Lipoproteins Pre-betaAntioxidantsBasal (phylogenetics)chemistry.chemical_compoundFenofibrateProspective StudiesHypolipidemic AgentsFenofibrateMiddle AgedOxidantsPON1Up-RegulationTreatment OutcomeDrug Therapy CombinationFemalelipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineNiacinmedicine.drugAdultmedicine.medical_specialtyNiacinbehavioral disciplines and activitiesInternal medicinemedicineHumansMetabolomicsParticle SizeAgedDyslipidemiasbusiness.industryCholesterolCholesterol HDLnutritional and metabolic diseasesmedicine.diseaseCrossover studyCross-Sectional StudiesEndocrinologyDiabetes Mellitus Type 2chemistrySpainSimvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessBiomarkersAtherosclerosis
researchProduct

Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.

2007

Objective— Apolipoprotein A5 ( APOA5 ) is a key determinant of plasma triglyceride (TG) concentrations. Genetic variation at the APOA5 locus could be responsible for some of the observed differences in response to fenofibrate therapy. Methods and Results— We examined the association between tag SNPs (−1131T>C and 56C>G) at APOA5 and TG and HDL-C response to fenofibrate and a postprandial lipid challenge in 791 men and women participating in the GOLDN study. After 3-week drug treatment, APOA5 56G carriers displayed significant decrease in TG ( P =0.006), and increase in HDL-C ( P =0.002) levels relative to their basal values in the fasting state when compared with noncarriers (a TG re…

MaleTime FactorsApolipoprotein BAdministration Oralchemistry.chemical_compoundFenofibrateGene FrequencyApolipoprotein a5Hypolipidemic AgentsAged 80 and overFenofibratebiologyMiddle AgedPostprandial PeriodPostprandialTreatment OutcomeArea Under CurveFemaleCardiology and Cardiovascular Medicinemedicine.drugAdultmedicine.medical_specialtyGuanineAdolescentGenotypeSingle-nucleotide polymorphismHyperlipidemiasPolymorphism Single NucleotideCytosineInternal medicinemedicineHumansParticle SizeApolipoproteins ATriglyceridesAgedTriglyceridebusiness.industryCholesterolCholesterol HDLCholesterol LDLDrug interactionLipid MetabolismDietary FatsUnited StatesEndocrinologychemistryApolipoprotein A-Vbiology.proteinbusinessThymineArteriosclerosis, thrombosis, and vascular biology
researchProduct

BRAIN-TARGETED SOLID LIPID NANOPARTICLES CONTAINING RILUZOLE: PREPARATION, CHARACTERIZATION AND BIODISTRIBUTION

2009

Aim: Developments within nanomedicine have revealed a great potential for drug delivery to the brain. In this study nanoparticulate systems as drug carriers for riluzole, with sufficiently high loading capacity and small particle size, were prepared to a reach therapeutic drug level in the brain. Materials & method: Solid lipid nanoparticles containing riluzole have great potential as drug-delivery systems for amyotrophic lateral sclerosis and were produced by using the warm oil-in-water microemulsion technique. The resulting systems obtained were approximately 88 nm in size and negatively charged. Drug-release profiles demonstrated that a drug release was dependent on medium pH. Biodi…

Maleamyotrophic lateral sclerosisBiodistributionMaterials scienceSOLID LIPID NANOPARTICLES BRAIN TARGETING RILUZOLEBiomedical EngineeringDrug delivery to the brainMedicine (miscellaneous)NanoparticleBioengineeringDevelopmentPharmacologyRats Sprague-DawleyPlasmaDrug StabilitySolid lipid nanoparticlemedicineAnimalsHumansGeneral Materials ScienceParticle Sizebiodistributionmodified releaseDrug CarriersRiluzoleBrainLipidsRiluzoleRatssolid lipid nanoparticlesNeuroprotective AgentsSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoNanomedicineNanoparticlesParticle sizeDrug carriermedicine.drug
researchProduct